KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Twist Bioscience (TWST) Assets Average (2018 - 2025)

Twist Bioscience (TWST) has disclosed Assets Average for 5 consecutive years, with $903.9 million as the latest value for Q1 2022.

  • On a quarterly basis, Assets Average changed N/A to $903.9 million in Q1 2022 year-over-year; TTM through Mar 2022 was $903.9 million, a N/A change, with the full-year FY2022 number at $831.7 million, up 51.09% from a year prior.
  • Assets Average was $903.9 million for Q1 2022 at Twist Bioscience, up from $744.1 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $903.9 million in Q1 2022 to a low of $140.1 million in Q4 2018.
  • A 5-year average of $417.4 million and a median of $227.5 million in 2019 define the central range for Assets Average.
  • Peak YoY movement for Assets Average: soared 35.34% in 2019, then surged 69.44% in 2020.
  • Twist Bioscience's Assets Average stood at $140.1 million in 2018, then surged by 35.34% to $189.6 million in 2019, then soared by 36.09% to $258.1 million in 2020, then soared by 188.34% to $744.1 million in 2021, then rose by 21.47% to $903.9 million in 2022.
  • Per Business Quant, the three most recent readings for TWST's Assets Average are $903.9 million (Q1 2022), $744.1 million (Q4 2021), and $713.7 million (Q3 2021).